In an article recently published in the journal Talanta, researchers demonstrated a new approach to enable the specific detection of biomarkers in human tear by employing an aptamer-based graphene affinity nanosensor.
The ability to detect and measure the biomarkers in undiluted physiological fluids allows the application of nanosensors in measuring the biological fluid samples whose dilutions are impractical.
Biomarkers for Tear Fluid
Tear fluid is receiving growing attention as biosensors with disease biomarkers, including metabolites, electrolytes, proteins, and enzymes, that provide information on the state of human health. Recently, affinity-based biosensors were developed to detect disease biomarkers. The affinity ligands in the biosensors may be aptamers or antibodies that recognize the target molecules.
Due to the salient features of aptamers and graphene, the aptamer-based affinity nanosensors realized on graphene field-effect transistors (GFETs) have received considerable attention. They allow the sensitive detection of a wide range of analytes from ions to proteins in clinical diagnostics. Graphene nanosensors have small footprints and are ideal detectors of biomarkers in tears.
Aptamer-based Graphene Affinity Nanobiosensor
In the present study, the researchers demonstrated a new approach for detecting and measuring the biomarkers in undiluted human tears by employing an aptamer-based graphene affinity nanosensor. The graphene conducting channel in GFET was protected with a polyethylene glycol (PEG) nanolayer whose selected thickness suppressed the adsorption of nonspecific molecules.
Modifying graphene with PEG of varying molecular weights restricted the nonspecific binding, enabling specificity and selectivity in biomarker detection in undiluted physiological fluids. The experimental results revealed that the fabricated nanosensor’s had the capacity to detect tumor necrosis factor alpha (TNF-α), an inflammatory cytokine, at a detection limit of 0.34 picomolar.
Research Findings
The biomarker (TNF-α) bound guanine-rich aptamer experienced conformational changes and transformed into a compact and stable G-quadruplex via folding. Consequently, the protein-bound negatively charged aptamer approached the graphene surface, resulting in the redistribution of carrier concentration, which increased the drain-source current with an increase in TNF-α concentration.
PEG-modified nanosensors and aptamer were tested in PBS for biomarker measurements. The results revealed that with the increase in TNF-α concentration from 0.008 to 125 nanomoles, the VDirac (Dirac point) decreased from 39 to 9 millivolts with nanosensors modified with PEG of 350-dalton molecular weight, indicating that the binding of aptamer and TNF-α introduced the n-type doping to the graphene.
Similarly, in nanosensors modified with PEG of 1000 and 2000 dalton molecular weight, with the increase in TNF-α concentration from 0.008 to 125 nanomoles, the VDirac (Dirac point) decreased from 55 to 27 millivolts and 30 to 1 millivolt, respectively.
The normalized Dirac point (ΔVDirac/ΔVDirac, max) was used as the representative for sensor output, which was calculated for both PEG-modified and non-PEG-modified devices, and was further plotted as a function of TNF-α concentration. With the increase in TNF-α concentration, a larger concentration of aptamer/ TNF-α complexes was observed, reflecting an increase in sensor output.
Fitting the Hill-Langmuir binding equation allowed the determination of equilibrium dissociation constant KD value of 3.22 nanomoles for non-PEG-modified nanosensors. On the other hand, the KD was found to be 2.17, 2.89, and 2.86 nanomoles for the devices with PEG of molecular weight 350, 1000, and 2000 Daltons, respectively.
The aforementioned KD values suggested that the presence of superficial PEG had no effect on the affinity between TNF-α and aptamer. However, at any given TNF-α concentration, PEG-modified devices had larger output than the non-PEG-modified devices, suggesting that PEG modification increased the Debye screening length on the surface of graphene.
Conclusion
In conclusion, the researchers demonstrated a facile approach to enable specific and sensitive TNF-α detection in undiluted tears in the eye by employing an aptamer-based graphene nanosensor.
The nanosensor was configured as GFET, and its graphene surface was modified with aptamer and PEG. The aptamer was specific in recognizing TNF-α, which induced a carrier change in graphene concentration. Measuring the carrier change determined the concentration of TNF-α.
The PEG nano layer reduced nonspecific adsorption, thereby increasing its specificity, which further depends on the molecular weight of PEG.
Thus, optimizing the PEG molecular weight and attachment method could allow sensitive and specific detection of other biomarkers in undiluted physiological fluids required in healthcare applications.
News
Scientists Unlock a New Way to Hear the Brain’s Hidden Language
Scientists can finally hear the brain’s quietest messages—unlocking the hidden code behind how neurons think, decide, and remember. Scientists have created a new protein that can capture the incoming chemical signals received by brain [...]
Does being infected or vaccinated first influence COVID-19 immunity?
A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important question: does it matter whether a person was first infected or first vaccinated? [...]
We May Never Know if AI Is Conscious, Says Cambridge Philosopher
As claims about conscious AI grow louder, a Cambridge philosopher argues that we lack the evidence to know whether machines can truly be conscious, let alone morally significant. A philosopher at the University of [...]
AI Helped Scientists Stop a Virus With One Tiny Change
Using AI, researchers identified one tiny molecular interaction that viruses need to infect cells. Disrupting it stopped the virus before infection could begin. Washington State University scientists have uncovered a method to interfere with a key [...]
Deadly Hospital Fungus May Finally Have a Weakness
A deadly, drug-resistant hospital fungus may finally have a weakness—and scientists think they’ve found it. Researchers have identified a genetic process that could open the door to new treatments for a dangerous fungal infection [...]
Fever-Proof Bird Flu Variant Could Fuel the Next Pandemic
Bird flu viruses present a significant risk to humans because they can continue replicating at temperatures higher than a typical fever. Fever is one of the body’s main tools for slowing or stopping viral [...]
What could the future of nanoscience look like?
Society has a lot to thank for nanoscience. From improved health monitoring to reducing the size of electronics, scientists’ ability to delve deeper and better understand chemistry at the nanoscale has opened up numerous [...]
Scientists Melt Cancer’s Hidden “Power Hubs” and Stop Tumor Growth
Researchers discovered that in a rare kidney cancer, RNA builds droplet-like hubs that act as growth control centers inside tumor cells. By engineering a molecular switch to dissolve these hubs, they were able to halt cancer [...]
Platelet-inspired nanoparticles could improve treatment of inflammatory diseases
Scientists have developed platelet-inspired nanoparticles that deliver anti-inflammatory drugs directly to brain-computer interface implants, doubling their effectiveness. Scientists have found a way to improve the performance of brain-computer interface (BCI) electrodes by delivering anti-inflammatory drugs directly [...]
After 150 years, a new chapter in cancer therapy is finally beginning
For decades, researchers have been looking for ways to destroy cancer cells in a targeted manner without further weakening the body. But for many patients whose immune system is severely impaired by chemotherapy or radiation, [...]
Older chemical libraries show promise for fighting resistant strains of COVID-19 virus
SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, University of California San Diego scientists and an international team of [...]
Lower doses of immunotherapy for skin cancer give better results, study suggests
According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal of the National [...]
Researchers highlight five pathways through which microplastics can harm the brain
Microplastics could be fueling neurodegenerative diseases like Alzheimer's and Parkinson's, with a new study highlighting five ways microplastics can trigger inflammation and damage in the brain. More than 57 million people live with dementia, [...]
Tiny Metal Nanodots Obliterate Cancer Cells While Largely Sparing Healthy Tissue
Scientists have developed tiny metal-oxide particles that push cancer cells past their stress limits while sparing healthy tissue. An international team led by RMIT University has developed tiny particles called nanodots, crafted from a metallic compound, [...]
Gold Nanoclusters Could Supercharge Quantum Computers
Researchers found that gold “super atoms” can behave like the atoms in top-tier quantum systems—only far easier to scale. These tiny clusters can be customized at the molecular level, offering a powerful, tunable foundation [...]
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
WASHINGTON -- A single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer, researchers reported Wednesday. HPV, or human papillomavirus, is very common and spread [...]
